124 related articles for article (PubMed ID: 10667571)
1. The HRAS1 minisatellite locus and risk of ovarian cancer.
Weitzel JN; Ding S; Larson GP; Nelson RA; Goodman A; Grendys EC; Ball HG; Krontiris TG
Cancer Res; 2000 Jan; 60(2):259-61. PubMed ID: 10667571
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.
Phelan CM; Rebbeck TR; Weber BL; Devilee P; Ruttledge MH; Lynch HT; Lenoir GM; Stratton MR; Easton DF; Ponder BA; Cannon-Albright L; Larsson C; Goldgar DE; Narod SA
Nat Genet; 1996 Mar; 12(3):309-11. PubMed ID: 8589723
[TBL] [Abstract][Full Text] [Related]
3. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus.
Krontiris TG; Devlin B; Karp DD; Robert NJ; Risch N
N Engl J Med; 1993 Aug; 329(8):517-23. PubMed ID: 8336750
[TBL] [Abstract][Full Text] [Related]
4. Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients.
Rosell R; Calvo R; Sánchez JJ; Maurel J; Guillot M; Monzó M; Núñez L; Barnadas A
Clin Cancer Res; 1999 Jul; 5(7):1849-54. PubMed ID: 10430091
[TBL] [Abstract][Full Text] [Related]
5. The HRAS1 variable number of tandem repeats and risk of breast cancer.
Tamimi RM; Hankinson SE; Ding S; Gagalang V; Larson GP; Spiegelman D; Colditz GA; Krontiris TG; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1528-30. PubMed ID: 14693748
[TBL] [Abstract][Full Text] [Related]
6. Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population.
Pierce LM; Sivaraman L; Chang W; Lum A; Donlon T; Seifried A; Wilkens LR; Lau AF; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1199-204. PubMed ID: 11097227
[TBL] [Abstract][Full Text] [Related]
7. HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years.
Firgaira FA; Seshadri R; McEvoy CR; Dite GS; Giles GG; McCredie MR; Southey MC; Venter DJ; Hopper JL
J Natl Cancer Inst; 1999 Dec; 91(24):2107-11. PubMed ID: 10601382
[TBL] [Abstract][Full Text] [Related]
8. Rare HRAS1 alleles are a risk factor for the development of brain tumors.
Vega A; Sobrido MJ; Ruiz-Ponte C; Barros F; Carracedo A
Cancer; 2001 Dec; 92(11):2920-6. PubMed ID: 11753967
[TBL] [Abstract][Full Text] [Related]
9. Current evidence on the relationship between HRAS1 polymorphism and breast cancer risk: a meta-analysis.
Zhang C; Lv GQ; Yu XM; Gu YL; Li JP; Du LF; Zhou P
Breast Cancer Res Treat; 2011 Jul; 128(2):467-72. PubMed ID: 21221763
[TBL] [Abstract][Full Text] [Related]
10. Specific H-Ras minisatellite alleles in breast cancer susceptibility.
Gosse-Brun S; Sauvaigo S; Daver A; Page M; Lortholary A; Larra F; Bignon YJ; Bernard-Gallon D
Anticancer Res; 1999; 19(6B):5191-6. PubMed ID: 10697533
[TBL] [Abstract][Full Text] [Related]
11. Hras1 VNTR alleles as susceptibility markers for lung cancer: relationship to microsatellite instability in tumors.
Lindstedt BA; Ryberg D; Zienolddiny S; Khan H; Haugen A
Anticancer Res; 1999; 19(6C):5523-7. PubMed ID: 10697610
[TBL] [Abstract][Full Text] [Related]
12. HRAS1 variable number of tandem repeats polymorphism and risk of bladder cancer.
van Gils CH; Conway K; Li Y; Taylor JA
Int J Cancer; 2002 Aug; 100(4):414-8. PubMed ID: 12115522
[TBL] [Abstract][Full Text] [Related]
13. Loss of the same alleles of HRAS1 and D11S151 in two independent pancreatic cancers from a patient with multiple endocrine neoplasia type 1.
Yoshimoto K; Iizuka M; Iwahana H; Yamasaki R; Saito H; Saito S; Sekiya T
Cancer Res; 1989 May; 49(10):2716-21. PubMed ID: 2565762
[TBL] [Abstract][Full Text] [Related]
14. HRAS1 minisatellite alleles in colorectal carcinoma: relationship to microsatelite instability.
Vega A; Barros F; Lleonart ME; Ramon y Cajal S; Carracedo A
Anticancer Res; 2001; 21(4A):2855-60. PubMed ID: 11724366
[TBL] [Abstract][Full Text] [Related]
15. [Study of HRas1 minisatellite frequencies in children with thyroid papillary cancer].
Iarmolinskiĭ DG; Kartel NA; Ermak G; Demidchik IuE; Figge J
Tsitol Genet; 2004; 38(1):9-14. PubMed ID: 15098441
[TBL] [Abstract][Full Text] [Related]
16. Distinct mutation patterns of breast cancer-associated alleles of the HRAS1 minisatellite locus.
Ding S; Larson GP; Foldenauer K; Zhang G; Krontiris TG
Hum Mol Genet; 1999 Mar; 8(3):515-21. PubMed ID: 9949211
[TBL] [Abstract][Full Text] [Related]
17. Minisatellite allele diversification: the origin of rare alleles at the HRAS1 locus.
Kasperczyk A; DiMartino NA; Krontiris TG
Am J Hum Genet; 1990 Nov; 47(5):854-9. PubMed ID: 2220825
[TBL] [Abstract][Full Text] [Related]
18. An allele of HRAS1 3'variable number of tandem repeats is a frailty allele: implication for an evolutionarily-conserved pathway involved in longevity.
Bonafè M; Barbi C; Olivieri F; Yashin A; Andreev KF; Vaupel JW; De Benedictis G; Rose G; Carrieri G; Jazwinski SM; Franceschi C
Gene; 2002 Mar; 286(1):121-6. PubMed ID: 11943467
[TBL] [Abstract][Full Text] [Related]
19. Population genetics of the HRAS1 minisatellite locus.
Devlin B; Krontiris T; Risch N
Am J Hum Genet; 1993 Dec; 53(6):1298-305. PubMed ID: 8250046
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
Ramus SJ; Kartsonaki C; Gayther SA; Pharoah PD; Sinilnikova OM; Beesley J; Chen X; McGuffog L; Healey S; Couch FJ; Wang X; Fredericksen Z; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Barile M; Viel A; Allavena A; Ottini L; Papi L; Gismondi V; Capra F; Radice P; Greene MH; Mai PL; Andrulis IL; Glendon G; Ozcelik H; ; Thomassen M; Gerdes AM; Kruse TA; Cruger D; Jensen UB; Caligo MA; Olsson H; Kristoffersson U; Lindblom A; Arver B; Karlsson P; Stenmark Askmalm M; Borg A; Neuhausen SL; Ding YC; Nathanson KL; Domchek SM; Jakubowska A; Lubiński J; Huzarski T; Byrski T; Gronwald J; Górski B; Cybulski C; Dębniak T; Osorio A; Durán M; Tejada MI; Benítez J; Hamann U; Rookus MA; Verhoef S; Tilanus-Linthorst MA; Vreeswijk MP; Bodmer D; Ausems MG; van Os TA; Asperen CJ; Blok MJ; Meijers-Heijboer HE; ; ; Peock S; Cook M; Oliver C; Frost D; Dunning AM; Evans DG; Eeles R; Pichert G; Cole T; Hodgson S; Brewer C; Morrison PJ; Porteous M; Kennedy MJ; Rogers MT; Side LE; Donaldson A; Gregory H; Godwin A; Stoppa-Lyonnet D; Moncoutier V; Castera L; Mazoyer S; Barjhoux L; Bonadona V; Leroux D; Faivre L; Lidereau R; Nogues C; Bignon YJ; Prieur F; Collonge-Rame MA; Venat-Bouvet L; Fert-Ferrer S; ; Miron A; Buys SS; Hopper JL; Daly MB; John EM; Terry MB; Goldgar D; ; Hansen Tv; Jønson L; Ejlertsen B; Agnarsson BA; Offit K; Kirchhoff T; Vijai J; Dutra-Clarke AV; Przybylo JA; Montagna M; Casella C; Imyanitov EN; Janavicius R; Blanco I; Lázaro C; Moysich KB; Karlan BY; Gross J; Beattie MS; Schmutzler R; Wappenschmidt B; Meindl A; Ruehl I; Fiebig B; Sutter C; Arnold N; Deissler H; Varon-Mateeva R; Kast K; Niederacher D; Gadzicki D; Caldes T; de la Hoya M; Nevanlinna H; Aittomäki K; Simard J; Soucy P; ; Spurdle AB; Holland H; Chenevix-Trench G; Easton DF; Antoniou AC;
J Natl Cancer Inst; 2011 Jan; 103(2):105-16. PubMed ID: 21169536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
